# Besponsa

NDC: 0008-0100
Generic name: inotuzumab ozogamicin
Labeler / Manufacturer: Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20170818

FDA application: BLA761040

## Active ingredients

- INOTUZUMAB OZOGAMICIN: .25 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0008-0100"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0008-0100
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cc7014b1-c775-411d-b374-8113248b4077